Trident Lifeline Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹33.72 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 32.49 per cent from ₹49.95 crore. This corresponds to a year-on-year *(YoY) growth of 42.82 per cent.
Operating Profit
Operating Profit stands at ₹8.52 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 22.40 per cent from ₹10.98 crore. This corresponds to a year-on-year *(YoY) growth of 64.80 per cent.
PBDT
PBDT stands at ₹8.23 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 30.55 per cent from ₹11.85 crore. This corresponds to a year-on-year *(YoY) growth of 52.69 per cent.
Profit Before Tax
Profit Before Tax stands at ₹6.61 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 37.76 per cent from ₹10.62 crore. This corresponds to a year-on-year *(YoY) growth of 68.19 per cent.
Net Profit
Net Profit stands at ₹5.07 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 25.44 per cent from ₹6.80 crore. This represents a 82.37 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Trident Lifeline Ltd Earnings
- YOY
- QOQ
Trident Lifeline Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Trident Lifeline Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Trident Lifeline Ltd Financial Reports
Trident Lifeline Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Trident Lifeline | 6.88% | 8.72% | 42.23% | 57.78% | 59.49% | 34.67% |
| Amanta Healthcar | 4.98% | -6.48% | -5.73% | 8.23% | 52.12% | 47.31% |
| Wanbury | 0.36% | -0.15% | -13.13% | -43.70% | -25.62% | -19.88% |
| Valiant Laborato | -2.47% | 2.82% | -0.63% | 88.64% | 91.88% | 43.60% |
| Haleos Labs Limited | -5.00% | -1.11% | 3.33% | -6.24% | 17.68% | 33.54% |
| Jenburkt Pharma | 2.44% | -0.54% | -4.46% | -14.20% | -7.01% | -10.49% |
| Medicamen Biotec | 0.34% | -3.43% | -6.35% | 25.53% | 20.75% | -7.40% |
Company Info
Company Information
Chairman/ED & CEO : Hardik J Desai
ED / MD / Promoter : Shravan Harikrishna Patel
Non-Exec & Non-Independent Dir : Maniya H Desai
Independent Non Exe. Director : Mishal Shailesh Patel
Independent Non Exe. Director : Falguni Bhavesh Jariwala
Whole-time Director : Rupaben Chetanbhai Jariwala
Director & CFO : ASHISH ANANDSINGH BAFNA
Company Sec. & Compli. Officer : Nikita Sharma